Pages

Thursday, 2 December 2021

Morning exposure to deep red light improves declining eyesight

 

Summary:
Just three minutes of exposure to deep red light once a week, when delivered in the morning, can significantly improve declining eyesight, finds a pioneering new study.
Date:
November 24, 2021
Source:
University College London

FULL STORY

Just three minutes of exposure to deep red light once a week, when delivered in the morning, can significantly improve declining eyesight, finds a pioneering new study by UCL researchers.

Published in Scientific Reports, the study builds on the team's previous work*, which showed daily three-minute exposure to longwave deep red light 'switched on' energy producing mitochondria cells in the human retina, helping boost naturally declining vision.

For this latest study, scientists wanted to establish what effect a single three-minute exposure would have, while also using much lower energy levels than their previous studies. Furthermore, building on separate UCL research in flies** that found mitochondria display 'shifting workloads' depending on the time of day, the team compared morning exposure to afternoon exposure.

In summary, researchers found there was, on average, a 17% improvement in participants' colour contrast vision when exposed to three minutes of 670 nanometre (long wavelength) deep red light in the morning and the effects of this single exposure lasted for at least a week. However, when the same test was conducted in the afternoon, no improvement was seen.

Scientists say the benefits of deep red light, highlighted by the findings, mark a breakthrough for eye health and should lead to affordable home-based eye therapies, helping the millions of people globally with naturally declining vision.

Lead author, Professor Glen Jeffery (UCL Institute of Ophthalmology), said: "We demonstrate that one single exposure to long wave deep red light in the morning can significantly improve declining vision, which is a major health and wellbeing issue, affecting millions of people globally.

"This simple intervention applied at the population level would significantly impact on quality of life as people age and would likely result in reduced social costs that arise from problems associated with reduced vision."

Naturally declining vision and mitochondria

In humans around 40 years old, cells in the eye's retina begin to age, and the pace of this ageing is caused, in part, when the cell's mitochondria, whose role is to produce energy (known as ATP) and boost cell function, also start to decline.

Mitochondrial density is greatest in the retina's photoreceptor cells, which have high energy demands. As a result, the retina ages faster than other organs, with a 70% ATP reduction over life, causing a significant decline in photoreceptor function as they lack the energy to perform their normal role.

In studying the effects of deep red light in humans, researchers built on their previous findings in mice, bumblebees and fruit flies, which all found significant improvements in the function of the retina's photoreceptors when their eyes were exposed to 670 nanometre (long wavelength) deep red light.

"Mitochondria have specific sensitivities to long wavelength light influencing their performance: longer wavelengths spanning 650 to 900nm improve mitochondrial performance to increase energy production," said Professor Jeffery.

Morning and afternoon studies

The retina's photoreceptor population is formed of cones, which mediate colour vision, and rods, which adapt vision in low/dim light. This study focused on cones*** and observed colour contrast sensitivity, along the protan axis (measuring red-green contrast) and the tritan axis (blue-yellow).

All the participants were aged between 34 and 70, had no ocular disease, completed a questionnaire regarding eye health prior to testing, and had normal colour vision (cone function). This was assessed using a 'Chroma Test': identifying coloured letters that had very low contrast and appeared increasingly blurred, a process called colour contrast.

Using a provided LED device all 20 participants (13 female and 7 male) were exposed to three minutes of 670nm deep red light in the morning between 8am and 9am. Their colour vision was then tested again three hours post exposure and 10 of the participants were also tested one week post exposure.

On average there was a 'significant' 17% improvement in colour vision, which lasted a week in tested participants; in some older participants there was a 20% improvement, also lasting a week.

A few months on from the first test (ensuring any positive effects of the deep red light had been 'washed out') six (three female, three male) of the 20 participants, carried out the same test in the afternoon, between 12pm to 1pm. When participants then had their colour vision tested again, it showed zero improvement.

Professor Jeffery said: "Using a simple LED device once a week, recharges the energy system that has declined in the retina cells, rather like re-charging a battery.

"And morning exposure is absolutely key to achieving improvements in declining vision: as we have previously seen in flies, mitochondria have shifting work patterns and do not respond in the same way to light in the afternoon -- this study confirms this."

For this study the light energy emitted by the LED torch was just 8mW/cm2, rather than 40mW/cm2, which they had previously used. This has the effect of dimming the light but does not affect the wavelength. While both energy levels are perfectly safe for the human eye, reducing the energy further is an additional benefit.

Home-based affordable eye therapies

With a paucity of affordable deep red-light eye-therapies available, Professor Jeffery has been working for no commercial gain with Planet Lighting UK, a small company in Wales and others, with the aim of producing 670nm infra-red eye ware at an affordable cost, in contrast to some other LED devices designed to improve vision available in the US for over $20,000.

"The technology is simple and very safe; the energy delivered by 670nm long wave light is not that much greater than that found in natural environmental light," Professor Jeffery said.

"Given its simplicity, I am confident an easy-to-use device can be made available at an affordable cost to the general public.

"In the near future, a once a week three-minute exposure to deep red light could be done while making a coffee, or on the commute listening to a podcast, and such a simple addition could transform eye care and vision around the world."

Study limitations

Despite the clarity of the results, researchers say some of the data are "noisy." While positive effects are clear for individuals following 670nm exposure, the magnitude of improvements can vary markedly between those of similar ages. Therefore, some caution is needed in interpretating the data. It is possible that there are other variables between individuals that influence the degree of improvement that the researchers have not identified so far and would require a larger sample size.

This research was funded by the Biotechnology and Biological Sciences Research Council, and Sight Research UK.

To help meet the costs of this research and future research, Professor Glen Jeffery's Lab at the UCL Institute of Ophthalmology receives donations via UCL's Give Now platform.

*Declining eyesight improved by looking at deep red light & Journals of Gerontology

** 'A day in the life of mitochondria reveals shifting workloads' in Scientific Reports

***Only cones not rods were tested in this study; similar previous research identified a comparable effect on cones and rods, satisfying the team any effect on cones could be translated to rods.


Story Source:

Materials provided by University College London. Note: Content may be edited for style and length.


Journal Reference:

  1. Harpreet Shinhmar, Chris Hogg, Magella Neveu, Glen Jeffery. Weeklong improved colour contrasts sensitivity after single 670 nm exposures associated with enhanced mitochondrial function. Scientific Reports, 2021; 11 (1) DOI: 10.1038/s41598-021-02311-1

Cite This Page:

University College London. "Morning exposure to deep red light improves declining eyesight." ScienceDaily. ScienceDaily, 24 November 2021. <www.sciencedaily.com/releases/2021/11/211124154118.htm>.







https://planetlighting.co.uk/


Introducing eyepower red

Our ground breaking new product designed to promote healthy vision.




https://eye-power.co.uk/


   

KEY
FEATURES

BOOST CELL
ENERGY

IMPROVE
VISION

SLOW RETINAL
AGEING

EXTEND EYE
HEALTH

WHY THIS AFFECTS YOU

It’s a fact that the retina in your eye ages faster than any other organ in your body.

From 40 years onward there are measurable signs that your vision is declining.

By the age of 70 your retina will have lost 30% of its photoreceptors.

Retinal ageing can have a possible impact on vision and eye health later in life. Anything that can help slow the ageing process is beneficial.

REVERSE RETINAL AGEING

Just 3 minutes every few days of low-brightness deep red light using eyepower red can help to maintain the health of your eyesight and could even reverse some of the effects of ageing by restoring certain lost visual functions.

HOW IT WORKS

.

THE PROBLEM WITH AGEING

The retina at the back of our eye captures images and allows us to ‘see’ and interpret the world around us. This needs a large energy source to function effectively.

As we age this energy source starts to wear out causing cells to die and bringing the risk of problems with our eyesight later in life.

PHOTOBIOMODULATION HOLDS THE KEY

Photobiomodulation involves using deep red light to recharge the batteries in cells. These batteries are called mitochondria and are key in regulating the ageing process.

IMPROVE VISION & SLOW DOWN AGEING

Recent studies at University College London and Moorfields Eye Hospital involved exposing groups of volunteers over 40 years of age to short bursts of deep red light.

This not only resulted in significant improvements in colour perception and night vision but also showed strong evidence that it slowed the pace of ageing of the retina.

TECHNICAL DATA

LIGHT SOURCEPremium grade 670nm Deep Red LED cluster
TIMER3 minute session timer with automatic switch off
BATTERYRechargeable battery with 2 weeks between charges
DIMENSIONS170mm x 165mm x 48mm
WEIGHT215 grams
ACCESSORIESProtective case with zip shutter  |   USB charger cable
WARRANTY2 Years

BEHIND THE SCENES

eyepower is a collaboration headed up by Planet Lighting Ltd – a long established UK lighting specialist – and industry experts in design and electronics.

eyepower red builds on the many years of research in to the therapeutic effects of deep red light in re-energising cells and in particular more recent work in to the significant benefits of deep red light in counteracting the effects of retinal ageing.

In recognition of the importance of near infra red therapy and its effect on human mitochondria, we will donate a minimum of 20% of the profits from sales of eyepower red to ophthalmic research at University College London. This will be used to help fund further studies and extend knowledge in this innovative field of preventative health care.

COUNTDOWN TO LAUNCH

JULY 2021

The final eyepower red prototype is tested and approved for production. Manufacturing plans initiated. Web site launched.

PLACE YOUR ORDER

Order your eyepower red now for early delivery on launch
for the special introductory price of just £36.50*.

*The offer will end after the official product launch.

NO RISK

You may cancel your order or return your eyepower red up to 30 days after delivery.

NO PAYMENT

Payment will only be collected when your eyepower red is ready to ship.

DELIVERY

Delivery will commence December 2021 on a first come first served basis. Shipping is to UK mainland.

If you are not resident in the UK please just enter your country in the Postcode field.  We will then confirm shipping costs and collect your full address details at point of payment if you proceed with the order.

RESEARCH FUNDING

Every eyepower red sold helps to fund ongoing research at University College London in to the use of deep red light to reduce the effects of retinal ageing.

£48.75
£36.50
+£4.75 p&p


Statin use affects prostate cancer screening results

 

Summary:
Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study finds. In statin users, screening did not increase the incidence of prostate cancer as it did in other men.
Date:
November 29, 2021
Source:
Tampere University

FULL STORY

Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did not increase the incidence of prostate cancer as it did in other men.

The study found the clearest difference in low-risk cancer, which is often overdiagnosed due to screening. The number of low-risk tumours found in screening was significantly lower in statin users. However, statin use caused no difference in the detection of high-risk cancers. In the screened group, prostate cancer mortality was slightly lower than in the unscreened group, both in men taking statins and other men.

"The study provides significant new information because statin use is very common and the effects of prostate cancer screening have not been previously evaluated in relation to statin use," says Professor Teemu Murtola from the Faculty of Medicine and Health Technology at Tampere University.

The study was published in the JAMA Oncology journal on 24 November 2021.

The findings may be explained by the fact that statin use improves the accuracy of prostate cancer screening. This means that screening detects dangerous types of cancer in these men as well as in others, but in statin users, there is less of the so-called overdiagnosis, which means the detection of low-risk prostate cancers that do not pose a health threat due to their very slow growth rate.

Another possible explanation could be that men who use statins are a select group who already actively use health services and have had PSA tests outside systematic screening. In those cases, the additional screening done in the study does not have such a great impact.

The study was based on data from the Finnish Prostate Cancer Screening Trial which started in 1996-1999. A total of about 80,000 men were included in the study, of whom just under 32,000 were screened with the PSA test every four years. The project was carried out jointly by Tampere University and the University of Helsinki and the Helsinki and Tampere University Hospitals.


Story Source:

Materials provided by Tampere University. Note: Content may be edited for style and length.


Journal Reference:

  1. Arla Vettenranta, Teemu J. Murtola, Jani Raitanen, Paavo Raittinen, Kirsi Talala, Kimmo Taari, Ulf-HÃ¥kan Stenman, Teuvo L. J. Tammela, Anssi Auvinen. Outcomes of Screening for Prostate Cancer Among Men Who Use Statins. JAMA Oncology, 2021; DOI: 10.1001/jamaoncol.2021.5672

Cite This Page:

Tampere University. "Statin use affects prostate cancer screening results." ScienceDaily. ScienceDaily, 29 November 2021. <www.sciencedaily.com/releases/2021/11/211129105542.htm>.




RELATED STORIES

Eating more plant foods may lower heart disease risk in young adults, older women

 

Summary:

Eating a plant-centered diet during young adulthood is associated with a lower risk of heart disease in middle age, according to a long-term study with about 30 years of follow-up. A separate study with about 15 years of follow-up found that eating more plant-based foods that have been shown to lower cholesterol, called the 'Portfolio Diet', is associated with lower risk of cardiovascular disease in postmenopausal women.

Date:
August 4, 2021
Source:
American Heart Association

FULL STORY

Eating more nutritious, plant-based foods is heart-healthy at any age, according to two research studies published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

In two separate studies analyzing different measures of healthy plant food consumption, researchers found that both young adults and postmenopausal women had fewer heart attacks and were less likely to develop cardiovascular disease when they ate more healthy plant foods.

The American Heart Association Diet and Lifestyle Recommendations suggest an overall healthy dietary pattern that emphasizes a variety of fruits and vegetables, whole grains, low-fat dairy products, skinless poultry and fish, nuts and legumes and non-tropical vegetable oils. It also advises limited consumption of saturated fat, trans fat, sodium, red meat, sweets and sugary drinks.

One study, titled "A Plant-Centered Diet and Risk of Incident Cardiovascular Disease during Young to Middle Adulthood," evaluated whether long-term consumption of a plant-centered diet and a shift toward a plant-centered diet starting in young adulthood are associated with a lower risk of cardiovascular disease in midlife.

"Earlier research was focused on single nutrients or single foods, yet there is little data about a plant-centered diet and the long-term risk of cardiovascular disease," said Yuni Choi, Ph.D., lead author of the young adult study and a postdoctoral researcher in the division of epidemiology and community health at the University of Minnesota School of Public Health in Minneapolis.

Choi and colleagues examined diet and the occurrence of heart disease in 4,946 adults enrolled in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Participants were 18- to 30-years-old at the time of enrollment (1985-1986) in this study and were free of cardiovascular disease at that time. Participants included 2,509 Black adults and 2,437 white adults (54.9% women overall) who were also analyzed by education level (equivalent to more than high school vs. high school or less). Participants had eight follow-up exams from 1987-88 to 2015-16 that included lab tests, physical measurements, medical histories and assessment of lifestyle factors. Unlike randomized controlled trials, participants were not instructed to eat certain things and were not told their scores on the diet measures, so the researchers could collect unbiased, long-term habitual diet data.

After detailed diet history interviews, the quality of the participants diets was scored based on the A Priori Diet Quality Score (APDQS) composed of 46 food groups at years 0, 7 and 20 of the study. The food groups were classified into beneficial foods (such as fruits, vegetables, beans, nuts and whole grains); adverse foods (such as fried potatoes, high-fat red meat, salty snacks, pastries and soft drinks); and neutral foods (such as potatoes, refined grains, lean meats and shellfish) based on their known association with cardiovascular disease.

Participants who received higher scores ate a variety of beneficial foods, while people who had lower scores ate more adverse foods. Overall, higher values correspond to a nutritionally rich, plant-centered diet.

"As opposed to existing diet quality scores that are usually based on small numbers of food groups, APDQS is explicit in capturing the overall quality of diet using 46 individual food groups, describing the whole diet that the general population commonly consumes. Our scoring is very comprehensive, and it has many similarities with diets like the Dietary Guidelines for Americans Healthy Eating Index (from the U.S. Department of Agriculture's Food and Nutrition Service), the DASH (Dietary Approaches to Stop Hypertension) diet and the Mediterranean diet," said David E. Jacobs Jr., Ph.D., senior author of the study and Mayo Professor of Public Health in the division of epidemiology and community health at the University of Minnesota School of Public Health in Minneapolis.

Researchers found:

  • During 32 years of follow-up, 289 of the participants developed cardiovascular disease (including heart attack, stroke, heart failure, heart-related chest pain or clogged arteries anywhere in the body).
  • People who scored in the top 20% on the long-term diet quality score (meaning they ate the most nutritionally rich plant foods and fewer adversely rated animal products) were 52% less likely to develop cardiovascular disease, after considering several factors (including age, sex, race, average caloric consumption, education, parental history of heart disease, smoking and average physical activity).
  • In addition, between year 7 and 20 of the study when participants ages ranged from 25 to 50, those who improved their diet quality the most (eating more beneficial plant foods and fewer adversely rated animal products) were 61% less likely to develop subsequent cardiovascular disease, in comparison to the participants whose diet quality declined the most during that time.
  • There were few vegetarians among the participants, so the study was not able to assess the possible benefits of a strict vegetarian diet, which excludes all animal products, including meat, dairy and eggs.

"A nutritionally rich, plant-centered diet is beneficial for cardiovascular health. A plant-centered diet is not necessarily vegetarian," Choi said. "People can choose among plant foods that are as close to natural as possible, not highly processed. We think that individuals can include animal products in moderation from time to time, such as non-fried poultry, non-fried fish, eggs and low-fat dairy."

Because this study is observational, it cannot prove a cause-and-effect relationship between diet and heart disease.

Other co-authors are Nicole Larson, Ph.D.; Lyn M. Steffen, Ph.D.; Pamela J. Schreiner, Ph.D.; Daniel D. Gallaher, Ph.D.; Daniel A. Duprez, M.D., Ph.D.; James M. Shikany, Dr.P.H.; and Jamal S. Rana, M.D., Ph.D.

The study was funded by the National Heart, Lung and Blood Institute of the National Institutes of Health; Healthy Food Healthy Lives Institute at the University of Minnesota; and the MnDrive Global Food Ventures Professional Development Program at the University of Minnesota.

In another study, "Relationship Between a Plant-Based Dietary Portfolio and Risk of Cardiovascular Disease: Findings from the Women's Health Initiative (WHI) Prospective Cohort Study," researchers, in collaboration with WHI investigators led by Simin Liu, M.D., Ph.D., at Brown University, evaluated whether or not diets that included a dietary portfolio of plant-based foods with U.S. Food and Drug Administration-approved health claims for lowering "bad" cholesterol levels (known as the "Portfolio Diet") were associated with fewer cardiovascular disease events in a large group of postmenopausal women.

The "Portfolio Diet" includes nuts; plant protein from soy, beans or tofu; viscous soluble fiber from oats, barley, okra, eggplant, oranges, apples and berries; plant sterols from enriched foods and monounsaturated fats found in olive and canola oil and avocadoes; along with limited consumption of saturated fats and dietary cholesterol. Previously, two randomized trials demonstrated that reaching high target levels of foods included in the Portfolio Diet resulted in significant lowering of "bad" cholesterol or low-density lipoprotein cholesterol (LDL-C), more so than a traditional low-saturated-fat National Cholesterol and Education Program diet in one study and on par with taking a cholesterol-lowering statin medication in another.

The study analyzed whether postmenopausal women who followed the Portfolio Diet experienced fewer heart disease events. The study included 123,330 women in the U.S. who participated in the Women's Health Initiative, a long-term national study looking at risk factors, prevention and early detection of serious health conditions in postmenopausal women. When the women in this analysis enrolled in the study between 1993 and 1998, they were between 50-79 years old (average age of 62) and did not have cardiovascular disease. The study group was followed until 2017 (average follow-up time of 15.3 years). Researchers used self-reported food-frequency questionnaires data to score each woman on adherence to the Portfolio Diet.

The researchers found:

  • Compared to women who followed the Portfolio Diet less frequently, those with the closest alignment were 11% less likely to develop any type of cardiovascular disease, 14% less likely to develop coronary heart disease and 17% less likely to develop heart failure.
  • There was no association between following the Portfolio Diet more closely and the occurrence of stroke or atrial fibrillation.

"These results present an important opportunity, as there is still room for people to incorporate more cholesterol-lowering plant foods into their diets. With even greater adherence to the Portfolio dietary pattern, one would expect an association with even less cardiovascular events, perhaps as much as cholesterol-lowering medications. Still, an 11% reduction is clinically meaningful and would meet anyone's minimum threshold for a benefit. The results indicate the Portfolio Diet yields heart-health benefits," said John Sievenpiper, M.D., Ph.D., senior author of the study at St. Michael's Hospital, a site of Unity Health Toronto in Ontario, Canada, and associate professor of nutritional sciences and medicine at the University of Toronto.

The researchers believe the results highlight possible opportunities to lower heart disease by encouraging people to consume more foods in the Portfolio Diet.

"We also found a dose response in our study, meaning that you can start small, adding one component of the Portfolio Diet at a time, and gain more heart-health benefits as you add more components," said Andrea J. Glenn, M.Sc., R.D., lead author of the study and a doctoral student at St. Michael's Hospital in Toronto and in nutritional sciences at the University of Toronto.

Although the study was observational and cannot directly establish a cause-and-effect relation between diet and cardiovascular events, researchers feel it provides a most reliable estimate for the diet-heart relation to-date due to its study design (included well-validated food frequency questionnaires administered at baseline and year three in a large population of highly dedicated participants). Nevertheless, the investigators report that these findings need to be further investigated in additional populations of men or younger women.

Co-authors are Kenneth Lo, Ph.D.; David J. A. Jenkins, M.D., Ph.D.; Beatrice A. Boucher, M.H.Sc.; Anthony J. Hanley, Ph.D.; Cyril W.C. Kendall, Ph.D.; JoAnn E. Manson, M.D., Dr.P.H.; Mara Z. Vitolins, Ph.D.; Linda G. Snetselaar, Ph.D.; and Simin Liu, M.D., Ph.D.

The study was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health and Diabetes Canada.


Story Source:

Materials provided by American Heart Association. Note: Content may be edited for style and length.


Journal References:

  1. Andrea J. Glenn, Kenneth Lo, David J. A. Jenkins, Beatrice A. Boucher, Anthony J. Hanley, Cyril W. C. Kendall, JoAnn E. Manson, Mara Z. Vitolins, Linda G. Snetselaar, Simin Liu, John L. Sievenpiper. Relationship Between a Plant‐Based Dietary Portfolio and Risk of Cardiovascular Disease: Findings From the Women's Health Initiative Prospective Cohort Study. Journal of the American Heart Association, 2021; DOI: 10.1161/JAHA.121.021515
  2. Yuni Choi, Nicole Larson, Lyn M. Steffen, Pamela J. Schreiner, Daniel D. Gallaher, Daniel A. Duprez, James M. Shikany, Jamal S. Rana, David R. Jacobs. Plant‐Centered Diet and Risk of Incident Cardiovascular Disease During Young to Middle Adulthood. Journal of the American Heart Association, 2021; DOI: 10.1161/JAHA.120.020718

https://www.sciencedaily.com/releases/2021/08/210804123607.htm


RELATED STORIES